Don't expect Johnson & Johnson's COVID vaccine to quickly lift U.S. supplies. Early shipments will be small, officials say Anthem, CloudMedx bringing COVID-19 tracking tool to vaccine distribution Everlywell’s home COVID-19 testing kit goes direct-to-consumer Bring on the boosters: Studies show Pfizer, Moderna COVID vaccines are less potent against aggressive variant Inspectors force AstraZeneca's Mexico vaccine partner to overhaul its factory, holding up shot production Businesses, public health organizations form alliance to strengthen COVID-19 response Amid AstraZeneca supply kerfuffle, Belgian plant blamed for shortfalls 'drastically' boosts capacity: report Uninsured rates among young people dropped under ACA: Urban Institute Featured Story | By Eric Sagonowsky Johnson & Johnson's easier-to-use, single-dose COVID-19 vaccine is nearing authorization, theoretically promising a major boost to the frantic U.S. immunization campaign. But J&J only has "a few million" doses ready to deliver right away, a White House advisor said Wednesday. read more |
| |
|---|
|
Top Stories By Paige Minemyer Anthem and CloudMedx are adding vaccine distribution data to their online COVID-19 data platform. read more By Conor Hale Everlywell’s home testing kit for COVID-19—first authorized by the FDA last year, for use with a doctor’s prescription—will now be available for sale directly to the consumer, through online orders or retail store shelves. read more By Arlene Weintraub In letters published in the New England Journal of Medicine, Pfizer and Moderna acknowledged that laboratory experiments showed their mRNA vaccines aren't as potent against the aggressive new COVID-19 variant identified in South Africa. Wall Street analysts are worried. read more By Kevin Dunleavy While Mexico is receiving small shipments of AstraZeneca's COVID-19 vaccines from overseas, two large shipments of the active ingredient used to make it remain unused. The holdup? Problems at a domestic factory tasked with finishing the shots, according to Mexico’s foreign minister Marcelo Ebrard. read more By Paige Minemyer Major business and public health organizations are teaming up to enhance the business community's response to the COVID-19 pandemic. read more By Fraiser Kansteiner Amid AstraZeneca's ongoing supply disputes with the European Union, Thermo Fisher's newly acquired Belgian plant—reportedly at the heart of those shortfalls—has "drastically" ramped up production capacity, an EU official said. read more By Paige Minemyer Young adults were among the most likely to be uninsured prior to the Affordable Care Act, but the law's Medicaid expansion had a significant impact on those rates, according to a new study. read more |
